)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
iZafe Group
iZafe Group (IZAFE-B) investor relations material
iZafe Group Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary3 Nov, 2026
Executive summary
Q3 net sales were SEK 1.8M and EBITDA was -SEK 6.5M; delayed customer rollouts and discounted pricing weighed on results, while costs reflect capacity built for larger volumes.
Existing agreements span 72 Swedish municipalities, ~30 Dutch healthcare organizations and 14 Norwegian municipalities; usage and implementation progress vary across markets.
Financial highlights
Q3 net sales were SEK 1,768K vs SEK 1,102K; the comparison excludes Dutch operations, whose consolidation drove the reported increase.
Q3 EBIT was -SEK 8,232K vs -SEK 3,273K; EBITDA was -SEK 6,451K vs -SEK 2,297K, reflecting Dutch consolidation, higher costs and acquisition-related amortization.
Q3 net result was -SEK 8,187K vs -SEK 3,537K; EPS was -SEK 0.02 vs -SEK 0.01.
9M net sales were SEK 6,826K vs SEK 3,556K; EBITDA was -SEK 16,624K vs -SEK 8,130K and net result was -SEK 22,128K vs -SEK 11,819K.
Q3 sales were below the prior quarter's SEK 2.6M; CEO cited postponed implementations and discounts tied to delivery delays.
Outlook and guidance
Year-end 2026 ARR forecast was revised to ~SEK 16M from SEK 22.5M; year-end 2027 forecast is ~SEK 36M.
The prior SEK 22.5M ARR target is now expected by June 30, 2027, dependent on installations, billable activations and greater use among existing customers.
New-generation Dosell deliveries have commenced; planned customer implementations and cost control are key to improving revenue, results and cash flow.
Västervik and cooperating municipalities could require ~500 Dosell units at full rollout, representing ~SEK 3.7M in ARR; volumes are estimates, not guaranteed.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from iZafe Group
- Sales surged but losses deepened; focus shifts to recurring revenue and faster installations.IZAFE-B
Q2 2026 - Recurring revenues drive growth, with ARR at 10 MSEK and European expansion underway.IZAFE-BQ4 2025
- Recurring revenues and major contracts drive strong growth outlook, despite ongoing losses.IZAFE-BQ1 2026
- Recurring revenue model established, ARR quadrupled, and European expansion accelerates.IZAFE-BQ3 2025
- Recurring revenue growth and European expansion drive strong momentum in Q2 2025.IZAFE-BQ2 2025
- Revenue surged as Dosell expanded, with losses narrowing and growth momentum accelerating.IZAFE-BQ3 2024
- Net sales fell in Q2, but demand and new contracts signal growth ahead.IZAFE-BQ2 2024
- Recurring revenues and international expansion drive improved results and future growth.IZAFE-BQ1 2025
- Revenue doubled and ARR surged as iZafe accelerates international expansion.IZAFE-BQ4 2024
Next iZafe Group earnings date
Q4 202616 Feb, 2027
iZafe Group
Next iZafe Group earnings date
Q4 202616 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
iZafe Group is a Swedish medical technology company specializing in the development and marketing of solutions aimed at enhancing medication safety and management at home. The company's flagship product, Dosell, is an automated drug dispenser that manages dose bags, ensuring medication is taken at the correct times and alerting users to missed doses. Additionally, iZafe Group offers Pilloxa, a smart pillbox solution, as part of its product lineup. iZafe Group is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq.